Please login to the form below

Not currently logged in
Email:
Password:

Hansa Medical poaches Vifor Pharma’s CEO

Søren Tulstrup becomes the Swedish biopharma’s CEO and president

Soren TulstropHansa Medical has appointed Søren Tulstrup as its new chief executive officer and president, roles that will see him succeed acting CEO Ulf Wiinberg who reverts to his former role as chairman of the Swedish biopharma.

Tulstrup was most recently CEO of Swiss pharmaceutical group Vifor Pharma and prior to this he served as senior vice president, global franchise head at Shire.

Ulf Wiinberg, chairman at Hansa Medical, said: “Søren is an accomplished life science industry executive, who brings diverse and extensive industry experience having built and led high-performance biopharma companies, country operations and teams both in Europe and the US.”

Additionally, Tulstrup has served as CEO of Santaris Pharma, now part of Roche, and in several senior commercial roles within Merck & Co and Sandoz Pharma.

Wiinberg concluded: “Søren’s strong track record of managing the development, launch and growth of biopharmaceuticals globally for the treatment of rare diseases and kidney diseases greatly matches Hansa Medical’s promising position.”

29th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics